Verified Nov 2026
Other
·

San Diego, California
·
Since 1993
Acadia Pharmaceuticals is a biopharmaceutical company headquartered in San Diego, California, founded in 1993. With 500-1,000 employees and estimated revenue of $1-5 billion, the company develops treatments for neurological disorders and rare diseases. Its commercial portfolio includes NUPLAZID for Parkinson's disease psychosis and DAYBUE for Rett syndrome, with a pipeline targeting Alzheimer's disease psychosis, Lewy body dementia, and other conditions.
Acadia Pharmaceuticals at a glance
Revenue
$1-5B
Est. band
Employees
500-1,000
Founded
1993
Headquarters
San Diego, California
Industries
Automotive
Electric Vehicles
Medical
Overview
Acadia Pharmaceuticals is a biopharmaceutical company headquartered in San Diego, California, founded in 1993. With 500-1,000 employees and estimated revenue of $1-5 billion, the company develops treatments for neurological disorders and rare diseases. Its commercial portfolio includes NUPLAZID for Parkinson's disease psychosis and DAYBUE for Rett syndrome, with a pipeline targeting Alzheimer's disease psychosis, Lewy body dementia, and other conditions.
At a glance
Attribute | Detail |
|---|---|
Founded | 1993 |
Headquarters | San Diego, California |
Employees | 500-1,000 |
Revenue | $1-5B (estimated) |
What Acadia Pharmaceuticals makes
Acadia's capabilities span small-molecule central nervous system therapies, FDA-approved drug development, and clinical research focused on underserved neurological and rare disease populations.
Latest developments
2026-11-04 — Acadia Pharmaceuticals - Acadia Pharmaceuticals Reports Third Quarter 2026 Financial Results (acadia.com)
2026-03-24 — Baker Brothers Renewed Their Acadia Exit Infrastructure - RxDataLab (rxdatalab.com)
2026-02-25 — Acadia Pharmaceuticals - Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview (acadia.com)
2026-01-13 — Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference (businesswire.com)
2025-11-17 — We’re proud to announce that Rafa, in partnership with Acadia Pharmaceuticals Inc., a biopharmaceutical company committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare … | Rafa (linkedin.com)
2025-10-31 — Kilroy Leases South San Francisco Offices to Acadia (therealdeal.com)
Company details
The company collaborates with pharmaceutical partners and serves neurologists, psychiatrists, and long-term care physicians globally. Acadia Pharmaceuticals was founded in 1993, has an estimated 500-1,000 employees, and is headquartered in San Diego, California.
Frequently asked questions
What does Acadia Pharmaceuticals do?
Acadia Pharmaceuticals is a biopharmaceutical company headquartered in San Diego, California, founded in 1993. With 500-1,000 employees and estimated revenue of $1-5 billion, the company develops treatments for neurological disorders and rare diseases. Its commercial portfolio includes NUPLAZID for Parkinson's disease psychosis and DAYBUE for Rett syndrome, with a pipeline targeting Alzheimer's disease psychosis, Lewy body dementia, and other conditions.
Where is Acadia Pharmaceuticals headquartered?
Acadia Pharmaceuticals is headquartered in San Diego, California.
When was Acadia Pharmaceuticals founded?
Acadia Pharmaceuticals was founded in 1993.
How big is Acadia Pharmaceuticals?
Acadia Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
